Clinical Trial: A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity

U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07137585) titled 'A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity' on Aug. 15.

Brief Summary: The main purpose of this study is to assess the effect of RO7204239 on insulin sensitivity versus placebo in participants with T2DM and obesity or overweight.

Study Start Date: Aug. 14

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Mellitus Obesity Overweight

Intervention: DRUG: Placebo

RO7204239 matching placebo will be administered as per the schedule specified in the treatment arm.

DRUG: RO7204239

RO7204239 will be admin...